医学
非酒精性脂肪肝
慢性肝病
药品
肝损伤
内科学
胃肠病学
肝病
脂肪肝
疾病
药理学
肝硬化
作者
Craig Lammert,Timothy D. Imler,Evgenia Teal,Naga Chalasani
标识
DOI:10.1016/j.cgh.2018.12.013
摘要
To date, there have been no studies that systematically examined if individuals with nonalcoholic fatty liver disease (NAFLD) have an increased risk of drug-induced liver injury (DILI). We conducted a study to test if the frequency of suspected DILI from prescription agents is higher in individuals with chronic liver disease (CLD) suggestive of NAFLD.
科研通智能强力驱动
Strongly Powered by AbleSci AI